Abstract 2752: Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer
Emil Christensen(Aarhus University Hospital), Lars Dyrskjøt(Aarhus University Hospital), Ellen C. Zwarthoff(Erasmus MC), Iver Nordentoft(Aarhus University Hospital), Kim van Kessel(Erasmus MC Cancer Institute), Mads Agerbæk(Aarhus University Hospital), Kirstin A. van der Keur(Erasmus MC Cancer Institute), Jørgen Bjerggaard Jensen(University Psychiatric Hospital), Karin Birkenkamp‐Demtröder(Aarhus University Hospital), Torben F. Ørntoft(Aarhus University Hospital), S. Høyer(Aarhus University Hospital)
Cited by 2
Related Papers
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
|Journal of Clinical Oncology|2019|540
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493